Last deal

$39.5M

Amount

Venture - Series Unknown

Stage

24.11.2023

Date

7

all rounds

$128.M

Total amount

General

About Company
Octave Bioscience is a molecular diagnostics company that focuses on neurodegenerative diseases and conditions.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2013

Number of employees

Company Type

For Profit

Last funding type

Venture - Series Unknown

IPO status

Private

Description

Their Precision Care Solution is the first-of-its-kind that accurately and objectively measures, and helps manage, complex and high-cost neurodegenerative diseases, starting with multiple sclerosis. The solution provides neurologists with a longitudinal and holistic perspective of the patient along with comprehensive and actionable insights, enabling more confident and informed care decisions. Octave also enables payers to reduce total cost of care and pharma to optimize the entire lifecycle of drug discovery & development as well as clinical trials and post marketing with real world evidence.
Contacts